Knight Therapeutics Inc. (TSX: GUD)
Canada
· Delayed Price · Currency is CAD
5.19
+0.03 (0.58%)
Dec 20, 2024, 4:00 PM EST
Knight Therapeutics Employees
Knight Therapeutics had 725 employees as of December 31, 2023. The number of employees increased by 27 or 3.87% compared to the previous year.
Employees
725
Change (1Y)
27
Growth (1Y)
3.87%
Revenue / Employee
480.88K CAD
Profits / Employee
-42.38K CAD
Market Cap
523.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bausch + Lomb Corporation | 13,300 |
Bausch Health Companies Inc. | 20,270 |
WELL Health Technologies Corp. | 1,507 |
dentalcorp Holdings Ltd. | 9,900 |
Tilray Brands, Inc. | 2,650 |
Curaleaf Holdings, Inc. | 5,650 |
Sienna Senior Living Inc. | 12,263 |
Cronos Group Inc. | 356 |
Knight Therapeutics News
- 9 days ago - Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Mexico - GlobeNewsWire
- 18 days ago - Andrey Omelchak's Past Pick: Lumine, Trisura Group and Knight Therapeutics - BNN Bloomberg
- 6 weeks ago - Knight Therapeutics Inc. (KHTRF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Knight Therapeutics Reports Third Quarter 2024 - GlobeNewsWire
- 7 weeks ago - Notice of Knight Therapeutics’ Third Quarter 2024 Results Conference Call - Financial Post
- 7 weeks ago - Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call - GlobeNewsWire
- 3 months ago - Knight Therapeutics Inc. places No. 397 on The Globe and Mail’s sixth annual ranking of Canada’s Top Growing Companies - Financial Post
- 3 months ago - Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies - GlobeNewsWire